Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)


  • Increased rates of dyslipidemia, abnormal glucose metabolism, and cardiovascular disease are seen in HIV-infected persons
  • Traditional risk factors, HIV-related factors, and ART-related factors contribute to the increased prevalence

Action required